奥浦迈1月26日获融资买入622.55万元,融资余额7835.33万元

Group 1 - The core viewpoint of the news is that Aopumai has shown significant growth in revenue and net profit, indicating a positive financial performance for the company [2] - As of January 26, Aopumai's stock price decreased by 1.60%, with a trading volume of 62.336 million yuan, and the net financing purchase was 1.1634 million yuan [1] - The financing balance of Aopumai is 78.3533 million yuan, which accounts for 1.23% of its market capitalization, indicating a low level compared to the past year [1] Group 2 - For the period from January to September 2025, Aopumai achieved an operating income of 272 million yuan, representing a year-on-year growth of 25.79% [2] - The net profit attributable to the parent company for the same period was 49.4253 million yuan, showing an impressive year-on-year increase of 81.48% [2] - Aopumai has distributed a total of 173 million yuan in dividends since its A-share listing [2]

Shanghai OPM Biosciences -奥浦迈1月26日获融资买入622.55万元,融资余额7835.33万元 - Reportify